Skip to content
Relatix Health

Relatix Health

Radically different

  • Participate
    • Start here
  • Services
    • Tests to participate in
  • Resources
  • About
    • Our Vision – A radically different future
    • Our mission – personalised lifelong support
    • News
    • FAQ
    • Contact
    • Trust and Privacy
    • Support us
  • Login

Author: admin

Posted on June 8, 2026

Fronto-Parietal Transcranial Alternating Current Stimulation for ADHD in Children and Adolescents

Conditions: Attention-Deficit/Hyperactivity Disorder

Interventions: Device: Active transcranial alternating current stimulation; Device: Sham transcranial alternating current stimulation

Sponsors: Central South University

Recruiting
Posted on June 8, 2026

Precision HD-tACS for Enhancing Sensory Experience in Schizophrenia

Conditions: SCHIZOPHRENIA 1 (Disorder); Sensory Perceptual Characteristics

Interventions: Device: Transcranial neurostimulation; Device: Sham Transcranial neurostimulation

Sponsors: Hôpital le Vinatier

Not yet recruiting
Posted on June 8, 2026

Magnesium Bisglycinate in Major Depressive Disorder

Conditions: Major Depressive Disorder

Interventions: Dietary Supplement: Magnesium Bisglycinate; Other: Microcrystalline cellulose

Sponsors: All India Institute of Medical Sciences, Bhubaneswar

Not yet recruiting
Posted on June 8, 2026

Serotonin Variants & Gut Microbiota in Mental Health: Pilot Study

Conditions: Major Depressive Disorder (MDD; Anxiety Disorder, Generalized; Stress Disorders, Post-Traumatic; Panic Disorder

Interventions: Diagnostic Test: SNP Genotyping and Gut Metagenomics

Sponsors: Neurobiologix

Not yet recruiting
Posted on June 8, 2026

Mind-Body Interventions in Coronary Artery Disease

Conditions: Coronary Artery Disease (CAD)

Interventions: Behavioral: Progressive Muscle Relaxation and Guided Imagery

Sponsors: şeyda candeniz

Not yet recruiting
Posted on June 8, 2026

Vortioxetine for Cognitive Function in ALK-positive NSCLC Treated With Lorlatinib

Conditions: Advanced ALK/ROS1-positive NSCLC; Carcinoma, Non-Small-Cell Lung (NSCLC); Lung Adenocarcinoma; ALK-positive Non-small Cell Lung Cancer (NSCLC); Cognitive Dysfunction; Depression

Sponsors: Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo

Recruiting
Posted on June 8, 2026

Moral Injury Study Among Healthcare Professionals in Psychiatric Facilities in the PACA Region

Conditions: Moral Injury

Interventions: Other: Self-Questionnaires for Healthcare Workers

Sponsors: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer; Direction Générale de l’Offre de Soins

Not yet recruiting
Posted on June 8, 2026

Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients Receiving Neoadjuvant/Preoperative Chemotherapy

Conditions: Oncology Patients Receiving Chemotherapy; Cachexia-Anorexia Syndrome; Oncology

Interventions: Drug: OLANZapine 2.5 MG

Sponsors: Blokhin’s Russian Cancer Research Center

Recruiting
Posted on June 8, 2026

Diagnostic Accuracy of GPT-4o and Claude 4.6 Sonnet in Turkish ED Anamnesis Notes

Conditions: Emergency Medicine; Diagnostic Errors; Artificial Intelligence (AI) in Diagnosis

Sponsors: Marmara University Pendik Training and Research Hospital

Not yet recruiting
Posted on June 8, 2026

Intelligent Screening and Precision Diagnosis of Prostate Cancer Based on Multimodal Data

Conditions: Prostate Cancer With PSA Gray Zone

Sponsors: Guangxi Medical University

Not yet recruiting

Posts pagination

Previous page Page 1 … Page 67 Page 68 Page 69 … Page 366 Next page

Relatix Health

Relatix Health helps people understand neurodiversity and mental health through science, lived experience, and compassionate, practical support. Want to recruit participants or reach the right customers faster and more fairly? Go to our sister site relatixbio.com.

  • X / Twitter
  • LinkedIn
  • YouTube

Company

  • About
  • Participate
  • Support Us
  • Mission
  • Vision
  • Contact

Resources

  • Services
  • Resources
  • News
  • FAQ

Legal

  • Privacy Policy
  • ESG
© 2026 Relatix Health. All rights reserved.